Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan: prospective observational study
Nur Haziqah Baharum, Sharifah Faradila Wan Muhammad Hatta, Nur Aisyah Zainordin, Rohana Abdul Ghani · 2024
Read Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan: prospective observational study by Nur Haziqah Baharum, Sharifah Faradila Wan Muhammad Hatta, Nur Aisyah Zainordin, Rohana Abdul Ghani (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11610116.txt.
Description
Nur Haziqah Baharum and colleagues compare three long-acting insulins in patients who fast for Ramadan, in this study from twenty twenty-four. Their patients had type 2 diabetes with mild to moderate kidney disease, a group doctors class as high risk for fasting. Modern insulin analogues are thought safer than older human insulin, but head-to-head data in this group were scarce.
Forty-six patients who chose to fast in Ramadan of twenty twenty-two wore glucose sensors and used one of three insulins: glargine, levemir, or Insulatard. Glucose swings and time spent too low were much the same across the three groups. Blood sugar control, kidney measures, weight, and waist size also ended the month much as they began. Small drops in weight or waist appeared in single groups only. The authors conclude that all three insulins served these fasting patients about equally well.
Catalog record
| CREATOR | Nur Haziqah Baharum, Sharifah Faradila Wan Muhammad Hatta, Nur Aisyah Zainordin, Rohana Abdul Ghani |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |